Hostile results of modest sleep restriction on sleepiness, efficiency, and inflammatory cytokines.
Whole sleep restriction in people is related to elevated daytime sleepiness, decreased efficiency, and hormonal/metabolic disturbances.
The results of delicate persistent sleep restriction that mimic actual life will not be recognized. To evaluate the results of modest sleep restriction from Eight to six h/night time for 1 wk, 25 younger, wholesome, regular sleepers (12 males and 13 girls) have been studied for 12 consecutive nights within the sleep laboratory.
After 1 wk of sleep restriction, though topics’ nighttime sleep was deeper, topics have been considerably sleepier (a number of sleep latency check) and carried out worse in4major variables of psychomotor vigilance check (each P < 0.01). Moreover, 24-h secretion of IL-6 was elevated by 0.8 +/- 0.three pg/ml (P < 0.05) in each sexes, whereas TNFalpha was elevated solely in males.
Additionally, the height cortisol secretion was decrease after sleep restriction than at baseline, and this distinction was stronger in males (55.18 +/- 24.83 nmol/liter; P < 0.05) than in girls (35.87 +/- 24.83 nmol/liter; P < 0.16). We conclude that in younger women and men, modest sleep loss is related to important sleepiness, impairment of psychomotor efficiency, and elevated secretion of proinflammatory cytokines.
Given the potential affiliation of those behavioral and bodily alterations with well being, well-being, and public security, the concept that sleep or elements of it are non-compulsory must be regarded with warning.
Human IL-17: a novel cytokine derived from T cells.
A cDNA encoding human IL-17 (hIL-17) was cloned from a CD4+ T cell library. The expected 155-amino acids sequence comprises an N-terminal sign peptide and displays 72% amino acid id with HVS13, an open studying body from a T-lymphotropic Herpesvirus saimiri, and 63% with murine CTLA8.
Excessive ranges of hIL-17 have been induced from major peripheral blood CD4+ T cells upon stimulation. When expressed in CV1/EBNA cells, recombinant hIL-17 was secreted in each glycosylated and nonglycosylated varieties. A hIL-17.Fc fusion protein and supernatants from cells transfected with hIL-17 induced IL-6 and IL-Eight manufacturing and enhanced the floor expression of the intracellular adhesion molecule-1 (ICAM-1) in human fibroblasts.
Olr641 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634589 | ABM | 1.0 ug DNA | EUR 514 |
Olr531 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634595 | ABM | 1.0 ug DNA | EUR 514 |
KRT9 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634601 | ABM | 1.0 ug DNA | EUR 682 |
Olr1560 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634607 | ABM | 1.0 ug DNA | EUR 514 |
Olr640 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634613 | ABM | 1.0 ug DNA | EUR 514 |
Olr462 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634619 | ABM | 1.0 ug DNA | EUR 514 |
Olr544 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634625 | ABM | 1.0 ug DNA | EUR 514 |
CIR1 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634631 | ABM | 1.0 ug DNA | EUR 682 |
VPS37A Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634637 | ABM | 1.0 ug DNA | EUR 682 |
SCIN Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634643 | ABM | 1.0 ug DNA | EUR 1355 |
Olr283 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634649 | ABM | 1.0 ug DNA | EUR 514 |
Olr464 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634655 | ABM | 1.0 ug DNA | EUR 514 |
Olr636 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634661 | ABM | 1.0 ug DNA | EUR 514 |
Olr545 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634667 | ABM | 1.0 ug DNA | EUR 514 |
Eci3 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634673 | ABM | 1.0 ug DNA | EUR 514 |
SPINK6 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634679 | ABM | 1.0 ug DNA | EUR 514 |
Olr1405 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634685 | ABM | 1.0 ug DNA | EUR 514 |
Olr465 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634691 | ABM | 1.0 ug DNA | EUR 514 |
Olr635 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634697 | ABM | 1.0 ug DNA | EUR 514 |
Olr546 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634703 | ABM | 1.0 ug DNA | EUR 514 |
Olr121 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634709 | ABM | 1.0 ug DNA | EUR 514 |
LARS Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634715 | ABM | 1.0 ug DNA | EUR 1355 |
WWTR1 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634721 | ABM | 1.0 ug DNA | EUR 682 |
Olr1238 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634727 | ABM | 1.0 ug DNA | EUR 514 |
Olr466 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634733 | ABM | 1.0 ug DNA | EUR 514 |
Olr634 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634739 | ABM | 1.0 ug DNA | EUR 514 |
Olr552 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634745 | ABM | 1.0 ug DNA | EUR 514 |
Olr122 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634751 | ABM | 1.0 ug DNA | EUR 514 |
Olr402 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634757 | ABM | 1.0 ug DNA | EUR 514 |
Olr469 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634763 | ABM | 1.0 ug DNA | EUR 514 |
Olr633 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634769 | ABM | 1.0 ug DNA | EUR 514 |
Olr596 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634775 | ABM | 1.0 ug DNA | EUR 514 |
Olr124 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634781 | ABM | 1.0 ug DNA | EUR 514 |
Olr1629 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634787 | ABM | 1.0 ug DNA | EUR 514 |
Olr470 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634793 | ABM | 1.0 ug DNA | EUR 514 |
Olr625 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634799 | ABM | 1.0 ug DNA | EUR 514 |
Olr629 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634805 | ABM | 1.0 ug DNA | EUR 514 |
RGD1304580 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634811 | ABM | 1.0 ug DNA | EUR 682 |
TMEM50B Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634817 | ABM | 1.0 ug DNA | EUR 514 |
Olr624 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634823 | ABM | 1.0 ug DNA | EUR 514 |
Olr472 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634829 | ABM | 1.0 ug DNA | EUR 514 |
PSMD3 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634835 | ABM | 1.0 ug DNA | EUR 682 |
Olr630 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634841 | ABM | 1.0 ug DNA | EUR 514 |
GTPBP8 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634847 | ABM | 1.0 ug DNA | EUR 514 |
Olr1143 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634853 | ABM | 1.0 ug DNA | EUR 514 |
Olr473 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634859 | ABM | 1.0 ug DNA | EUR 514 |
Olr623 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634865 | ABM | 1.0 ug DNA | EUR 514 |
DDX5 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634871 | ABM | 1.0 ug DNA | EUR 682 |
Olr662 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634877 | ABM | 1.0 ug DNA | EUR 514 |
Olr205 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634883 | ABM | 1.0 ug DNA | EUR 514 |
Olr476 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634889 | ABM | 1.0 ug DNA | EUR 514 |
Olr621 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634895 | ABM | 1.0 ug DNA | EUR 514 |
GALK1 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634901 | ABM | 1.0 ug DNA | EUR 682 |
Olr671 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634907 | ABM | 1.0 ug DNA | EUR 514 |
Olr136 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634913 | ABM | 1.0 ug DNA | EUR 514 |
NDUFC2 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634919 | ABM | 1.0 ug DNA | EUR 514 |
PLEKHG2 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634925 | ABM | 1.0 ug DNA | EUR 2154 |
Olr349 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634931 | ABM | 1.0 ug DNA | EUR 514 |
Olr477 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634937 | ABM | 1.0 ug DNA | EUR 514 |
Olr613 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634943 | ABM | 1.0 ug DNA | EUR 514 |
Olr677 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634949 | ABM | 1.0 ug DNA | EUR 514 |
Olr139 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634955 | ABM | 1.0 ug DNA | EUR 514 |
NTAN1 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634961 | ABM | 1.0 ug DNA | EUR 514 |
Olr1249 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634967 | ABM | 1.0 ug DNA | EUR 514 |
Olr479 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634973 | ABM | 1.0 ug DNA | EUR 514 |
Olr608 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634979 | ABM | 1.0 ug DNA | EUR 514 |
Olr696 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634985 | ABM | 1.0 ug DNA | EUR 514 |
MRPS18A Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634991 | ABM | 1.0 ug DNA | EUR 514 |
GTF2IRD1 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV634997 | ABM | 1.0 ug DNA | EUR 1355 |
Olr51 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV635003 | ABM | 1.0 ug DNA | EUR 514 |
Olr484 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV635009 | ABM | 1.0 ug DNA | EUR 514 |
Olr604 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV635015 | ABM | 1.0 ug DNA | EUR 514 |
Olr697 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV635021 | ABM | 1.0 ug DNA | EUR 514 |
BRMS1 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV635027 | ABM | 1.0 ug DNA | EUR 514 |
RFWD2 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV635033 | ABM | 1.0 ug DNA | EUR 682 |
EAPP Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV635039 | ABM | 1.0 ug DNA | EUR 514 |
Prss46 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV635045 | ABM | 1.0 ug DNA | EUR 514 |
Herpesvirus Saimiri encodes a brand new cytokine, IL-17, which binds to a novel cytokine receptor.
Herpesvirus Saimiri gene 13 (HVS13) displays 57% id with the anticipated sequence of a T cell-derived molecule termed CTLA8.
Recombinant HVS13 and CTLA8 stimulate transcriptional issue NF-kappa B exercise and interleukin-6 (IL-6) secretion in fibroblasts, and costimulate T cell proliferation. An HVS13.Fc fusion protein was used to isolate a cDNA encoding a novel receptor that additionally binds CTLA8. This receptor is unrelated to beforehand recognized cytokine receptor households.
A recombinant soluble receptor inhibited T cell proliferation and IL-2 manufacturing induced by PHA, concanavalin A (conA), and anti-TCR MAb. These outcomes outline CTLA8 and HVS13 as novel cytokines that bind to a novel cytokine receptor. We suggest to name these molecules IL-17, vIL-17, and IL-17R, respectively.
Inflammatory cytokines and postmyocardial infarction transforming.
Inflammatory response and cytokine elaboration are significantly energetic after myocardial infarction and contribute to cardiac transforming and eventual host consequence. The triggers of cytokine launch within the acute postinfarction interval embody mechanical deformation, ischemic stimulus, reactive oxygen species (ROS), and cytokine self-amplification pathways.
Acutely, the elaboration of tumor necrosis issue, IL-1 and IL-6, remodeling development issue households of cytokines, contribute to survival or deaths of myocytes, modulation of cardiac contractility, alterations of vascular endothelium, and recruitment of extra circulating cells of irritation to the injured myocardium.
This results in additional native oxidative stress and transforming but additionally initiates the processes of wound therapeutic. Chronically, sustained presence of cytokines results in myocyte phenotype transition and activation of matrix metalloproteinases that modifies interstitial matrix, augmenting additional the reworking course of. This in flip alters the native collagen composition and in addition the integrins that represent the interface between myocytes and the matrix.
These processes in the end, when favorable, pave the best way for angiogenesis and mobile regeneration. Thus, the insightful modulation of cytokines by way of present and future therapies might promote improved therapeutic and cardiac transforming postmyocardial infarction.
EF1a Control lentiviral particles (GFP-Puro) |
|||
| EF1a-Null-GP | GenTarget | 1 x107 IFU/ml x 200ul | EUR 349 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Puromycin fusion marker under RSV promoter. |
|||
EF1a Control lentiviral particles (RFP-Bsd) |
|||
| EF1a-Null-RB | GenTarget | 1 x107 IFU/ml x 200ul | EUR 349 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Blasticidin fusion marker under RSV promoter. |
|||
EF1a Control lentiviral particles (RFP-Puro) |
|||
| EF1a-Null-RP | GenTarget | 1 x107 IFU/ml x 200ul | EUR 349 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Puromycin fusion marker under RSV promoter. |
|||
EF1a Control lentiviral particles (Bsd) in PBS |
|||
| EF1a-Null-Bsd-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 710 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the blasticidin marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
EF1a Control lentiviral particles (Neo) in PBS |
|||
| EF1a-Null-Neo-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 710 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Neomycin marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
EF1a Control lentiviral particles (Puro) in PBS |
|||
| EF1a-Null-Puro-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 710 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Puromycin marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
EF1a Control lentiviral particles (GFP-Bsd) in PBS |
|||
| EF1a-Null-GB-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 710 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Blasticidin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
EF1a Control lentiviral particles (GFP-Puro) in PBS |
|||
| EF1a-Null-GP-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 710 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Puromycin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
EF1a Control lentiviral particles (RFP-Bsd) in PBS |
|||
| EF1a-Null-RB-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 710 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Blasticidin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
EF1a Control lentiviral particles (RFP-Puro) in PBS |
|||
| EF1a-Null-RP-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 710 |
|
Description: Negative control lentivirus contains a null spacer insert under EF1a promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Puromycin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
Olr461 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634584 | ABM | 1.0 ug DNA | EUR 514 |
Olr641 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634590 | ABM | 1.0 ug DNA | EUR 514 |
Olr531 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634596 | ABM | 1.0 ug DNA | EUR 514 |
KRT9 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634602 | ABM | 1.0 ug DNA | EUR 682 |
Olr1560 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634608 | ABM | 1.0 ug DNA | EUR 514 |
Olr640 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634614 | ABM | 1.0 ug DNA | EUR 514 |
Olr462 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634620 | ABM | 1.0 ug DNA | EUR 514 |
Olr544 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634626 | ABM | 1.0 ug DNA | EUR 514 |
CIR1 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634632 | ABM | 1.0 ug DNA | EUR 682 |
VPS37A Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634638 | ABM | 1.0 ug DNA | EUR 682 |
SCIN Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634644 | ABM | 1.0 ug DNA | EUR 1355 |
Olr283 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634650 | ABM | 1.0 ug DNA | EUR 514 |
Olr464 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634656 | ABM | 1.0 ug DNA | EUR 514 |
Olr636 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634662 | ABM | 1.0 ug DNA | EUR 514 |
Olr545 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634668 | ABM | 1.0 ug DNA | EUR 514 |
Eci3 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634674 | ABM | 1.0 ug DNA | EUR 514 |
SPINK6 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634680 | ABM | 1.0 ug DNA | EUR 514 |
Olr1405 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634686 | ABM | 1.0 ug DNA | EUR 514 |
Olr465 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634692 | ABM | 1.0 ug DNA | EUR 514 |
Olr635 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634698 | ABM | 1.0 ug DNA | EUR 514 |
Olr546 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634704 | ABM | 1.0 ug DNA | EUR 514 |
Olr121 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634710 | ABM | 1.0 ug DNA | EUR 514 |
LARS Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634716 | ABM | 1.0 ug DNA | EUR 1355 |
WWTR1 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634722 | ABM | 1.0 ug DNA | EUR 682 |
Olr1238 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634728 | ABM | 1.0 ug DNA | EUR 514 |
Olr466 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634734 | ABM | 1.0 ug DNA | EUR 514 |
Olr634 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634740 | ABM | 1.0 ug DNA | EUR 514 |
Olr552 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634746 | ABM | 1.0 ug DNA | EUR 514 |
Olr122 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634752 | ABM | 1.0 ug DNA | EUR 514 |
Olr402 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634758 | ABM | 1.0 ug DNA | EUR 514 |
Olr469 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634764 | ABM | 1.0 ug DNA | EUR 514 |
Olr633 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634770 | ABM | 1.0 ug DNA | EUR 514 |
Olr596 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634776 | ABM | 1.0 ug DNA | EUR 514 |
Olr124 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634782 | ABM | 1.0 ug DNA | EUR 514 |
Olr1629 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634788 | ABM | 1.0 ug DNA | EUR 514 |
Olr470 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634794 | ABM | 1.0 ug DNA | EUR 514 |
Olr625 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634800 | ABM | 1.0 ug DNA | EUR 514 |
Olr629 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634806 | ABM | 1.0 ug DNA | EUR 514 |
RGD1304580 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634812 | ABM | 1.0 ug DNA | EUR 682 |
TMEM50B Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634818 | ABM | 1.0 ug DNA | EUR 514 |
Olr624 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634824 | ABM | 1.0 ug DNA | EUR 514 |
Olr472 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634830 | ABM | 1.0 ug DNA | EUR 514 |
PSMD3 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634836 | ABM | 1.0 ug DNA | EUR 682 |
Olr630 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634842 | ABM | 1.0 ug DNA | EUR 514 |
GTPBP8 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634848 | ABM | 1.0 ug DNA | EUR 514 |
Olr1143 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634854 | ABM | 1.0 ug DNA | EUR 514 |
Olr473 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634860 | ABM | 1.0 ug DNA | EUR 514 |
Olr623 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634866 | ABM | 1.0 ug DNA | EUR 514 |
DDX5 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634872 | ABM | 1.0 ug DNA | EUR 682 |
Olr662 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634878 | ABM | 1.0 ug DNA | EUR 514 |
Olr205 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634884 | ABM | 1.0 ug DNA | EUR 514 |
Olr476 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634890 | ABM | 1.0 ug DNA | EUR 514 |
Olr621 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634896 | ABM | 1.0 ug DNA | EUR 514 |
GALK1 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634902 | ABM | 1.0 ug DNA | EUR 682 |
Olr671 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634908 | ABM | 1.0 ug DNA | EUR 514 |
Olr136 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634914 | ABM | 1.0 ug DNA | EUR 514 |
NDUFC2 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634920 | ABM | 1.0 ug DNA | EUR 514 |
PLEKHG2 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634926 | ABM | 1.0 ug DNA | EUR 2154 |
Olr349 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634932 | ABM | 1.0 ug DNA | EUR 514 |
Olr477 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634938 | ABM | 1.0 ug DNA | EUR 514 |
Olr613 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634944 | ABM | 1.0 ug DNA | EUR 514 |
Olr677 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634950 | ABM | 1.0 ug DNA | EUR 514 |
Olr139 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634956 | ABM | 1.0 ug DNA | EUR 514 |
NTAN1 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634962 | ABM | 1.0 ug DNA | EUR 514 |
Olr1249 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634968 | ABM | 1.0 ug DNA | EUR 514 |
Olr479 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634974 | ABM | 1.0 ug DNA | EUR 514 |
Olr608 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV634980 | ABM | 1.0 ug DNA | EUR 514 |
